On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2017: Volume 22/ Issue 10 Article 3
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 22, Issue 10, 09 March 2017
Rovida, Piralla, Marzani, Moreno, Campanini, Mojoli, Pozzi, Girello, Chiapponi, Vezzoli, Prati, Percivalle, Pavan, Gramegna, Iotti, and Baldanti: Authors’ reply: Two severe human cases due to swine influenza A (H1N1)v in October 2016 in Europe were chronologic coincident yet distinct events

+ Author affiliations

Citation style for this article: Rovida F, Piralla A, Marzani FC, Moreno A, Campanini G, Mojoli F, Pozzi M, Girello A, Chiapponi C, Vezzoli F, Prati P, Percivalle E, Pavan A, Gramegna M, Iotti GA, Baldanti F. Authors’ reply: Two severe human cases due to swine influenza A (H1N1)v in October 2016 in Europe were chronologic coincident yet distinct events. Euro Surveill. 2017;22(10):pii=30480. DOI:

Received:02 March 2017; Accepted:09 March 2017

To the editor: Indeed, the similarities between the cases reported by Fraaij et al. from the Netherlands [1] and our group in Italy [2] are somewhat striking. Both cases occurred in October 2016, both cases presented with severe respiratory syndrome and in both cases, a swine influenza virus (SIV) strain circulating in a nearby pig farm was detected in the patient. In the paper by Fraaij et al., the patient had visited a pig farm, but not had direct contact with pigs [1]. In our paper, the patient stated that he had no contact with infected pigs, but his brother worked on a pig farm. Although the data presented in our paper strictly adhere with official reports [2], we also agree that unreported visits to a pig farm or direct contact with infected pigs through contaminated surfaces or via aerosol are possibilities that cannot be excluded. However, a major difference between the Dutch and Italian case were the SIV strains recovered from the patients, indicating the occurrence of chronologically coincidental yet distinct events.

We share all the concerns raised by the Authors of the Letter to the editor [3]. In particular: (i) attention to severe zoonotic influenza A infections in humans should be as high in Europe as in any other region of the world. (ii) Both reported cases occurred earlier than the influenza season in humans and this event may have had an impact on established surveillance procedures and reporting which are activated at the beginning of the season. (iii) Virus whole genome sequencing should be the gold standard for specimens with inconclusive results or nontypeable influenza strains (indeed, this approach was followed by both the Dutch and Italian groups). (iv) We strongly recommend the inclusion of pan-influenza A molecular assays in the work-up of all patients with severe respiratory syndromes, irrespective of seasonality. (v) We fully support the need for unrestricted sharing of biological materials as well as epidemiological, clinical and sequence data.

In addition, we support the suggestion for follow-up investigations in patients with a documented SIV infection, a task that might not be easy to achieve. As far as our recent experience is concerned, at a follow-up telephone visit on 7 February 2017 [2]. As confirmed by his brother, the former patient was well, but not available for further questions.

Finally, we would like to emphasise that swine influenza monitoring programmes at the Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER) have been in place since the late 1990s, especially in northern Italy where more than 75% of the Italian swine industry is located. These programmes (further improved since 2009) are mainly based on genome detection, virus isolation and sequencing of all respiratory forms and revealing continuous circulation of H1N1, H3N2 and H1N2 SIVs as well as the isolation of influenza A(H1N1)pdm09 viruses in pigs.

Moreover, surveillance of SIV circulating in European pigs is carried out in many countries, mainly in western Europe, involving the networks European Surveillance Network for Influenza in Pigs (ESNIP 1, 2 and 3) which are aimed at expanding our knowledge on European SIV epidemiology [4]. However, judging by the small number of available SIV sequences, SIV surveillance appears to be less rigorous and systematic in other parts of Europe.

Conflict of interest

None declared.


  1. Fraaij PL, Wildschut ED, Houmes RJ, Swaan CM, Hoebe CJ, de Jonge HC,  et al.  Severe acute respiratory infection caused by swine influenza virus in a child necessitating extracorporeal membrane oxygenation (ECMO), the Netherlands, October 2016. Euro Surveill. 2016;21(48):30416. DOI: 10.2807/1560-7917.ES.2016.21.48.30416 PMID: 27934581

  2. Rovida F, Piralla A, Marzani FC, Moreno A, Campanini G, Mojoli F,  et al.  Swine influenza A (H1N1) virus (SIV) infection requiring extracorporeal life support in an immunocompetent adult patient with indirect exposure to pigs, Italy, October 2016. Euro Surveill. 2017;22(5):30456. DOI: 10.2807/1560-7917.ES.2017.22.5.30456 PMID: 28183395

  3. Adlhoch C, Penttinen P. Letter to the editor: Just a coincidence? Two severe human cases due to swine influenza (SIV) A(H1N1)v in Europe, October 2016. Euro Surveill. 2017;22(10):pii=30478.

  4. Simon G, Larsen LE, Dürrwald R, Foni E, Harder T, Van Reeth K, et al. European Surveillance Network for Influenza in Pigs: Surveillance programs, diagnostic tools and swine influenza virus subtypes identified in 14 European countries from 2010 to 2013. PLoS One. 2014;9(12):e115815. 10.1371/journal.pone.0115815 , 2014.

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.